webinar recording available - register to watch

The benefits of running clinical trials in China

China offers a significant opportunity for biotech companies to accelerate their clinical development. During this brief we will discuss:

  • The latest research and trends of biotech clinical trials in China
  • How regulatory requirements compare with the US, and what are the benefits for biotechnology companies to involve sites in China
  • Feedback from sponsors and investigators
watch now
watch the webinar

No cost to register, subject to confirmation

By registering for this event, you accept that you may receive direct communication from the sponsor(s).

If you are experiencing problems with your registration, please try the Zoom registration page.

Charley Sha

Charley Sha

Director of Regulatory Affairs at PPC CRO
Louisa Tsang

Louisa Tsang

Managing Director Clinical Research Management Office and Phase 1 Clinical Trial Centre at the Chinese University of Hong Kong
Dr. Tony Zhou

Tony Zhou

Head of Clinical Operations at SIMR Biotech
Arsalan Arif
moderator

arsalan arif

Founder & CEO, Endpoints News